The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) brings together regulatory authorities and the pharmaceutical industry to discuss the scientific and technical aspects of pharmaceutical development.
Through working groups of regulatory and industry experts, ICH produces harmonised technical requirements to ensure the development and registration of safe, effective, and high-quality medicines.
A webinar on 6 Feb, 2026 will present the draft E22 Guideline on patient preference studies, seeking to encourage stakeholder feedback.
Find the agenda and information on how to attendIndustry-leading standards for medical development.
Harmonisation achievements in the Quality area include pivotal milestones such as the conduct of stability studies, defining relevant thresholds for impurities...
Learn MoreICH produces a standardised reference tool for medical terminology (MedDRA) available in 27 languages for regulatory information transfer.
Learn MoreAssembly and MedDRA Steering Committee meetings.
Assembly meeting following Management Committee sessions.